Antonia S.
- Country
- Italy
- Department
- Medical and Surgical Sciences
Research Overview
- Switch Maintenance with Paclitaxel, Ramucirumab and Tislelizumab vs Continued Chemotherapy plus Tislelizumab in HER2‑negative, PD‑L1‑positive Gastroesophageal Adenocarcinoma
- Evaluation of Trastuzumab Deruxtecan and Fluoropyrimidine Versus Standard Chemotherapy in HER2-Positive Gastric or Gastroesophageal Cancer with Minimal Residual Disease
- Phase II Study of Tremelimumab and Durvalumab in Resectable MSI-High Gastric and Gastroesophageal Junction Cancer
Data & Insights
Has run more than one trial at 21 of 49 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating gastric cancer and gastroesophageal junction cancer, with particular emphasis on resectable cases and innovative treatment approaches.
- Upper GI Tract Malignancies
- Surgical Oncology Integration
- Digestive System Cancers
Advanced expertise in managing localized gastrointestinal malignancies and implementing multimodal treatment strategies.
Precision Medicine
Focuses on personalized treatment approaches utilizing molecular biomarkers including microsatellite instability (MSI) status and HER2-positive disease for targeted therapies.
- Molecular Diagnostics
- Biomarker-Driven Treatment
- Liquid Biopsy Analysis
Implements cutting-edge diagnostic techniques for treatment selection and monitoring disease response.
Immunotherapy
Specializes in immunotherapeutic approaches for gastrointestinal cancers, including combination therapies and novel treatment strategies in the pre-surgical setting.
- Neoadjuvant Immunotherapy
- Combination Treatment Protocols
- Targeted Antibody Therapies
Expertise in implementing innovative immunotherapy protocols for optimizing treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.